Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse. Increased noradrenaline in the brain has long been implicated in opiate withdrawal, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of beta-noradrenergic-receptor antagonists, or of an alpha2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the stress-induced reinstatement of drug-related responding in animal models appears to depend on the activation of both CRF and norepinephrine in elements of the extended amygdala (ie, central nucleus of the amygdala and bed nucleus of the stria terminalis; tables 1, 2, circuits 16 and 17)22,33,53,96–98 and the ventral tegmental area (tables 1, 2, circuit 9).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
In the citing paper
“As tolerance and withdrawal develop, brain stress systems, such as CRF, norepinephrine, and dynorphin, are recruited in the extended amygdala and contribute to the development of negative emotional states in withdrawal and protracted abstinence (tables 1, 2, circuits 6–8).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
Citations
Cites
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Paxinos, G. (1985) · Cited by 3,715
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 1×
“Increased noradrenaline during opiate withdrawal has also been linked to decreased dopamine in the NA”
BackgroundSchulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
The Lower Brainstem and Bodily Homeostasis
Loewy, A. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01234-x · Cited by 260
The Lower Brainstem and Bodily Homeostasis
Blessing, W. W. (1997) · Cited by 254
Tejani-Butt, S. M. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11249-4 · Cited by 239
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Self-citation
Research works printed but not linked: 2
- Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
- McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
Cited by
Items 201–300 of 491
Stone, E. A., Lehmann, M. L., Lin, Y., & Quartermain, D. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.020 · Cited by 55
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 54
Park, J., Bucher, E. S., Fontillas, K., Owesson-White, C., Ariansen, J. L., Carelli, R. M., & Wightman, R. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.008 · Cited by 53
Opioid withdrawal: role in addiction and neural mechanisms
Monroe, S. C., & Radke, A. K. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06370-2 · Cited by 53
Bruijnzeel, A. W., Bishnoi, M., van Tuijl, I. A., Keijzers, K. F. M., Yavarovich, K. R., Pasek, T. M., Ford, J., Alexander, J. C., & Yamada, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1970-0 · Cited by 53
New directions in the genetic mechanisms underlying nicotine addiction
Munafo, M. R., Johnstone, E. C., Murphy, M. F. G., & Walton, R. T. (2001) · Addiction Biology · doi:10.1080/13556210020040181 · Cited by 53
Central α1-adrenergic system in behavioral activity and depression
Stone, E. A., Quartermain, D., Lin, Y., & Lehmann, M. L. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.001 · Cited by 52
Georges, F. E., & Aston‐Jones, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300161 · Cited by 50
Self-citationOzdemir, D., Allain, F., Kieffer, B. L., & Darcq, E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109524 · Cited by 49
Neuroadaptive Responses in Brainstem Noradrenergic Nuclei Following Chronic Morphine Exposure
Bockstaele, E. J. V., Menko, A. S., & Drolet, G. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:155 · Cited by 49
Morphine produces circuit-specific neuroplasticity in the bed nucleus of the stria terminalis
Dumont, É. C., Rycroft, B. K., Maiz, J., & Williams, J. T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.039 · Cited by 49
Stone, E. A., Lehmann, M. L., Lin, Y., & Quartermain, D. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.010 · Cited by 49
What is the bed nucleus of the stria terminalis?
Dumont, É. C. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.006 · Cited by 48
Veinante, P., Stoeckel, M., Lasbennes, F., & Freund‐Mercier, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02837.x · Cited by 47
Skelly, M. J., & Weiner, J. L. (2014) · Brain and Behavior · doi:10.1002/brb3.230 · Cited by 47
Harris, N. A., Isaac, A., Günther, A., Merkel, K., Melchior, J. R., Xu, M., Eguakun, E., Perez, R. E., Nabit, B. P., Flavin, S. A., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0963-18.2018 · Cited by 47
Brain Norepinephrine Rediscovered in Addiction Research
Aston‐Jones, G., & Kalivas, P. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.016 · Cited by 47
Self-citationReciprocal Catecholamine Changes during Opiate Exposure and Withdrawal
Fox, M. E., Rodeberg, N. T., & Wightman, R. M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.135 · Cited by 47
Gieryk, A., Ziółkowska, B., Solecki, W., Kubik, J., & Przewłocki, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1730-1 · Cited by 46
Luster, B. R., Cogan, E. S., Schmidt, K. T., Pati, D., Pina, M. M., Dange, K., & McElligott, Z. A. (2019) · Addiction Biology · doi:10.1111/adb.12748 · Cited by 46
Brain pathways to recovery from alcohol dependence
Cui, C., Noronha, A., Warren, K. R., Koob, G. F., Sinha, R., Thakkar, M., Matochik, J., Crews, F. T., Chandler, L. J., Pfefferbaum, A., et al. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.006 · Cited by 45
Noradrenaline is necessary for the hedonic properties of addictive drugs
Jasmin, L., Mena, N., & Tien, D. A. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2005.08.030 · Cited by 46
Deyama, S., Katayama, T., Kondoh, N., Nakagawa, T., Kaneko, S., Yamaguchi, T., Yoshioka, M., & Minami, M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.024 · Cited by 45
Motivational valence is determined by striatal melanocortin 4 receptors
Klawonn, A. M., Fritz, M., Nilsson, A., Bonaventura, J., Shionoya, K., Mirrasekhian, E., Karlsson, U., Jaarola, M., Granseth, B., Blomqvist, A. G., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97854 · Cited by 45
The involvement of α2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice
Özdoğan, Ü. K., Lähdesmäki, J., Hakala, K., & Scheinin, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.051 · Cited by 45
Watanabe, T., Yamamoto, R., Maeda, A., Nakagawa, T., Minami, M., & Satoh, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03468-6 · Cited by 44
Molecular Changes in Opioid Addiction: The Role of Adenylyl Cyclase and cAMP/PKA System
Chan, P., & Lutfy, K. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.005 · Cited by 43
The role of the central noradrenergic system in behavioral inhibition
Stone, E. A., Lin, Y., Sarfraz, Y., & Quartermain, D. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.02.002 · Cited by 41
The anxiogenic drug yohimbine activates central viscerosensory circuits in rats
Myers, E. A., Banihashemi, L., & Rinaman, L. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20727 · Cited by 41
Cecchi, M., Capriles, N., Watson, S. J., & Akil, H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301140 · Cited by 41
Burnham, N. W., & Thiele, T. E. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.027 · Cited by 41
Núñez, C., Martín, F., Földes, A., Luisa Laorden, M., Kovács, K. J., & Victoria Milanés, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06765.x · Cited by 40
Behavioral Activation Induced by D2-Like Receptor Stimulation during Opiate Withdrawal
Druhan, J. P., Walters, C. L., & Aston‐Jones, G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39103-7 · Cited by 39
Self-citationNoradrenergic circuits and signaling in substance use disorders
Downs, A. M., & McElligott, Z. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108997 · Cited by 38
Hott, S. C., Gomes, F. V., Fabri, D. R. S., dos Reis, D. G., Crestani, C. C., Corrêa, F. M. D. A., & Resstel, L. B. M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01985.x · Cited by 38
Pati, D., Pina, M. M., & Kash, T. L. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0349-0 · Cited by 38
Kozicz, T. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02129.x · Cited by 38
Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal
Akbarian, S., Bates, B., Liu, R.-J., Skirboll, S. L., Pejchal, T., Coppola, V., Sun, L. D., Fan, G., Kučera, J., Wilson, M. A., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000897 · Cited by 38
Francesconi, W., Berton, F., Koob, G. F., & Sanna, P. P. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.003 · Cited by 37
Nagano, Y., Kaneda, K., Maruyama, C., Ide, S., Kato, F., & Minami, M. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.059 · Cited by 37
Chen, Y.-W., Das, M., Oyarzabal, E. A., Cheng, Q., Plummer, N. W., Smith, K. G., Jones, G. K., Malawsky, D. S., Yakel, J. L., Shih, Y. I., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0245-8 · Cited by 37
Chapter 10 Neuronal Mechanisms for Pain‐Induced Aversion
Minami, M. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85010-1 · Cited by 37
The neurocircuitry of addiction: Implications for treatment
Koob, G. F. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.005 · Cited by 37
Early life experience shapes the functional organization of stress-responsive visceral circuits
Rinaman, L., Banihashemi, L., & Koehnle, T. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.008 · Cited by 37
ICV testosterone induces Fos in male Syrian hamster brain
DiMeo, A. N., & Wood, R. I. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.001 · Cited by 37
McGinty, V. B., Hayden, B. Y., Heilbronner, S. R., Dumont, E. C., Graves, S. M., Mirrione, M. M., du Hoffmann, J., Sartor, G. C., España, R. A., Millan, E. Z., et al. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.036 · Cited by 36
Glass, M. J., Hegarty, D. M., Oselkin, M., Quimson, L., South, S. M., Xu, Q., Pickel, V. M., & Inturrisi, C. E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.045 · Cited by 36
Fox, M. E., Studebaker, R. I., Swofford, N. J., & Wightman, R. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.23 · Cited by 36
Walters, C. L., Aston-Jones, G., & Druhan, J. P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00113-5 · Cited by 36
Self-citationZaragoza, J. N., Núñez, C., Ruiz‐Medina, J., Laorden, M. L., Valverde, O., & Milanés, M. V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01090.x · Cited by 35
Neuronal Correlates of Hyperalgesia and Somatic Signs of Heroin Withdrawal in Male and Female Mice
Álvarez-Bagnarol, Y., Marchette, R. C. N., Francis, C., Morales, M., & Vendruscolo, L. F. (2022) · eNeuro · doi:10.1523/eneuro.0106-22.2022 · Cited by 35
Jin, C., Araki, H., Nagata, M., Suemaru, K., Shibata, K., Kawasaki, H., Hamamura, T., & Gomita, Y. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1844-4 · Cited by 35
Garcia, A. S., Barrera, G., Burke, T. F., Ma, S., Hensler, J. G., & Morilak, D. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02748.x · Cited by 35
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Carboni, E., Carta, A. R., Carboni, E., & Novelli, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.657714 · Cited by 35
Almela, P., Zaragoza, J. N., García-Carmona, J. A., Mora, L., Hidalgo, J. M., Milanés, M. V., & Laorden, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047089 · Cited by 33
Mu, L., Hou, Y., Lu, B., Chen, J., Chi, Z., & Liu, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.10 · Cited by 33
Kaneko, T., Kaneda, K., Ohno, A., Takahashi, D., Hara, T., Amano, T., Ide, S., Yoshioka, M., & Minami, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13419 · Cited by 32
2A-Adrenergic Receptors Filter Parabrachial Inputs to the Bed Nucleus of the Stria Terminalis
Flavin, S. A., Matthews, R. T., Wang, Q., Muly, E., & Winder, D. G. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0822-14.2014 · Cited by 32
Nakamura, T., Shimada, Y., Takeda, T., Sato, K., Akiba, M., & Fukaya, H. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.62 · Cited by 32
Bockstaele, E. J. V., Peoples, J. F., Menko, A. S., McHugh, K. M., & Drolet, G. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08659.2000 · Cited by 32
Glass, M. J., Kruzich, P. J., Kreek, M. J., & Pickel, V. M. (2004) · Synapse · doi:10.1002/syn.20049 · Cited by 32
Johnson, A., Peoples, J. F., Stornetta, R. L., & Bockstaele, E. J. V. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03367-x · Cited by 32
Tian, G., Hui, M., Macchia, D., Derdeyn, P., Rogers, A., Hubbard, E., Liu, C., Vasquez, J. J., Taniguchi, L., Bartas, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110775 · Cited by 31
“For example, noradrenergic projections in the BNST lead to activation of BNST cells during opiate withdrawal, and corticotropin-releasing factor (CRF) mRNA and protein levels are elevated in the BNST during protracted withdrawal (Delfs et al., 2000; Olive et al., 2002; Shalev et al., 2001).”
Brown, Z. J., Nóbrega, J. N., & Erb, S. M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.09.025 · Cited by 31
Toward a systems-oriented approach to the role of the extended amygdala in adaptive responding
Waraczynski, M. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.015 · Cited by 31
Reward, Motivation, and Addiction
Koob, G. F., Everitt, B. J., & Robbins, T. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00041-x · Cited by 31
Schulteis, G., Morse, A. C., & Liu, J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.006 · Cited by 31
Jadzic, D., Bassareo, V., Carta, A. R., & Carboni, E. (2019) · Addiction Biology · doi:10.1111/adb.12864 · Cited by 30
Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
Kaplan, G. B., & Thompson, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1253736 · Cited by 30
Liu, J., Pan, H., Gold, M. S., Derendorf, H., & Bruijnzeel, A. W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.034 · Cited by 30
Buller, K. M., Allen, T., Wilson, L. D., Munro, F., & Day, T. A. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.013 · Cited by 30
Chronic very low dose naltrexone administration attenuates opioid withdrawal expression
Mannelli, P., Gottheil, E., Peoples, J. F., Oropeza, V. C., & Bockstaele, E. J. V. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.013 · Cited by 30
du Hoffmann, J., Kim, J. J., & Nicola, S. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00349.2011 · Cited by 29
Different neural systems mediate morphine reward and its spontaneous withdrawal aversion
Vargas-Pérez, H., Ting‐A‐Kee, R. A., & van der Kooy, D. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06749.x · Cited by 29
Beckerman, M. A., & Glass, M. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.034 · Cited by 29
Erb, S. M., Funk, D. R., & Lê, A. D. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.013 · Cited by 29
Zheng, H., & Rinaman, L. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12123 · Cited by 29
Opiate Withdrawal Induces Narp in the Extended Amygdala
Reti, I. M., & Baraban, J. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300205 · Cited by 29
Longoni, R., Spina, L., Vinci, S., & Acquas, E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2192-9 · Cited by 28
Contribution of limbic norepinephrine to cannabinoid-induced aversion
Carvalho, A. F., Reyes, A.-R. S., Sterling, R. C., Unterwald, E. M., & Bockstaele, E. J. V. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1923-7 · Cited by 28
Fritz, M., Klawonn, A. M., Jaarola, M., & Engblom, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.020 · Cited by 28
Dyuizen, I. V., & Lamash, N. E. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.10.005 · Cited by 28
Bockstaele, E. J. V., Qian, Y., Sterling, R. C., & Page, M. E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.02.004 · Cited by 28
Src‐dependent phosphorylation of μ‐opioid receptor at Tyr336 modulates opiate withdrawal
Zhang, L., Kibaly, C., Wang, Y., Xu, C., Song, K. Y., McGarrah, P. W., Loh, H. H., Liu, J., & Law, P. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607324 · Cited by 27
Roth‐Deri, I., Friedman, A., Abraham, L., Lax, E., Flaumenhaft, Y., Dikshtein, Y., & Yadid, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06840.x · Cited by 27
Kwok, C. H. T., Harding, E. K., Burma, N. E., Markovic, T., Massaly, N., van den Hoogen, N. J., Stokes-Heck, S., Gambeta, E., Komarek, K., Yoon, H. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50657-7 · Cited by 26
The role of the bed nucleus of the stria terminalis in pain-induced aversive motivation
Minami, M. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.10.003 · Cited by 26
Goncharuk, V. D., Zeng, Z., Wang, R., MacTavish, D., & Jhamandas, J. H. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20132 · Cited by 26
Santos‐Toscano, R., Arévalo, M., García‐Segura, L. M., Grassi, D., & Lagunas, N. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101085 · Cited by 25
García-Carmona, J. A., Almela, P., Baroja‐Mazo, A., Milanés, M. V., & Laorden, M. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2478-y · Cited by 25
Opioids inhibit visceral afferent activation of catecholamine neurons in the solitary tract nucleus
Cui, R. J., Roberts, B. L., Zhao, H., Andresen, M. C., & Appleyard, S. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.010 · Cited by 25
Parlato, R., Cruz, H. G., Otto, C., Murtra, P., Parkitna, J. M. R., Martín, M., Bura, S. A., Begus‐Nahrmann, Y., Halbach, O. V. B. U., Maldonado, R. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06709.x · Cited by 25
Zaragoza, J. N., Hidalgo, J. M., Laorden, M. L., & Milanés, M. V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01918.x · Cited by 25
Harris, A. C., Atkinson, D. M., Aase, D. M., & Gewirtz, J. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.048 · Cited by 25
Peripheral withdrawal recruits distinct central nuclei in morphine-dependent rats
Hamlin, A. S., Buller, K. M., Day, T. A., & Osborne, P. B. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00101-0 · Cited by 25
Santibáñez, M., Gysling, K., & Forray, M. I. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20538 · Cited by 25
Neurochemistry Underlying Relapse to Opiate Seeking Behaviour
Brown, R. M., & Lawrence, A. J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9967-y · Cited by 24
Harris, N. A., & Winder, D. G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00169 · Cited by 24
Snyder, A. E., & Silberman, Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108814 · Cited by 24
Glass, M. J. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82008-4 · Cited by 24
Metadata
- Authors
- Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G.
- Affiliations
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
- Venue
- Nature
- Published
- 2000-01
- Volume
- 403
- Issue
- 6768
- Pages
- 430-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1659240124
- Semantic Scholar
- 973cb279566f11006ae21f697af863157189bf18
- Cited by
- 462
- References
- 31
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 3 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 11 · 2016: 12 · 2015: 18 · 2014: 8 · 2013: 18 · 2012: 24
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- norepinephrine, opioid withdrawal, conditioned place aversion, bed nucleus of the stria terminalis, caudal medulla, noradrenergic projections, alpha-2 adrenergic agonists, locus coeruleus, ventral forebrain, aversive conditioning
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic beta-Antagonists, Amygdala, Animals, Clonidine, Male, Narcotics, Neurons, Afferent, Norepinephrine, Propanolamines, Propranolol, Substance Withdrawal Syndrome, Tyrosine 3-Monooxygenase, Betaxolol, Prosencephalon, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.